Racura Oncology Ltd (RAC.AX) Deep Dive Video

Name: Racura Oncology Ltd (RAC.AX) Deep Dive Video | Flash
Uploaded: 2026-03-23T20:08:06.309375
Description: A reformulated “lost” AML drug resurfaces as a potential MYC-silencing G4 platform—huge upside if RC220 bridges cleanly, but execution and trial binary risk remain decisive.

Summary

A reformulated “lost” AML drug resurfaces as a potential MYC-silencing G4 platform—huge upside if RC220 bridges cleanly, but execution and trial binary risk remain decisive.

View RAC.AX stock page · Read the RAC.AX research report

Loading the video player…